Recordati Industria Chimica e Farmaceutica SPA (IT:REC)
:REC
Want to see IT:REC full AI Analyst Report?
Total Valuation
Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of €10.47B. The enterprise value is €12.31B.
Market Cap€10.47B
Enterprise Value€12.31B
Share Statistics
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding209,125,150
Owned by Insiders0.14%
Owned by Institutions―
Financial Efficiency
Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 12.11%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)12.11%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee571.70K
Profits Per Employee96.86K
Employee Count4,580
Asset Turnover0.50
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 16.3. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 3.24.
PE Ratio16.3
PS Ratio3.81
PB Ratio5.20
Price to Fair Value5.20
Price to FCF19.49
Price to Operating Cash Flow19.36
PEG Ratio3.24
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.62B and earned 443.62M in profits. Earnings per share was 2.16.
Revenue2.62B
Gross Profit1.79B
Operating Income719.74M
Pretax Income581.27M
Net Income443.62M
EBITDA887.00M
Earnings Per Share (EPS)2.16
Cash Flow
In the last 12 months, operating cash flow was 534.98M and capital expenditures -87.76M, giving a free cash flow of 447.21M billion.
Operating Cash Flow534.98M
Free Cash Flow447.21M
Free Cash Flow per Share2.14
Dividends & Yields
Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of €0.63, resulting in a dividend yield of 2.67%
Dividend Per Share€0.63
Dividend Yield2.67%
Payout Ratio46.43%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-0.65%
50-Day Moving Average48.01
200-Day Moving Average48.91
Relative Strength Index (RSI)65.79
Average Volume (3m)218.69K
Important Dates
Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is Jul 28, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateJul 28, 2026
Ex-Dividend Date―
Financial Position
Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.59, with Debt / Equity ratio of 114.88%
Current Ratio1.59
Quick Ratio1.08
Debt to Market Cap0.24
Net Debt to EBITDA2.30
Interest Coverage Ratio7.25
Taxes
In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 137.65M in taxes.
Income Tax137.65M
Effective Tax Rate0.24
Enterprise Valuation
Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 13.54, with an EV/FCF ratio of 23.47.
EV to Sales4.59
EV to EBITDA13.54
EV to Free Cash Flow23.47
EV to Operating Cash Flow20.13
Balance Sheet
Recordati Industria Chimica e Farmaceutica SPA has €380.47M in cash and marketable securities with €2.37B in debt, giving a net cash position of -€1.99B billion.
Cash & Marketable Securities€380.47M
Total Debt€2.37B
Net Cash-€1.99B
Net Cash Per Share-€9.50
Tangible Book Value Per Share-€6.18
Margins
Gross margin is 69.38%, with operating margin of 27.49%, and net profit margin of 16.94%.
Gross Margin69.38%
Operating Margin27.49%
Pretax Margin22.20%
Net Profit Margin16.94%
EBITDA Margin33.88%
EBIT Margin25.99%
Analyst Forecast
The average price target for Recordati Industria Chimica e Farmaceutica SPA is €56.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€56.75
Price Target Upside12.60% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast9.87%
EPS Growth Forecast13.63%